Drug Topics

APRIL 16, 2024

Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.

Vaccines 154

Vaccines Insurance 154

Drug Topics

JANUARY 18, 2024

In 2023, the FDA approved six vaccines, including 2 for respiratory syncytial virus (RSV), and the first vaccine to prevent the mosquito-borne virus chikungunya.

Vaccines 187

Vaccines FDA 187

Drug Topics

NOVEMBER 24, 2023

Study authors recommend that healthcare personnel consider prioritizing influenza vaccination for patients with recent cardiovascular diseases (CVDs) in light of new evidence.

Vaccines 232

Vaccines 232

STAT

JANUARY 25, 2024

A historic new study out of Scotland shows the real-world impact of vaccines against the human papillomavirus: The country has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV between the ages of 12 and 13.

Vaccines 145

Vaccines 145

Drug Topics

JANUARY 5, 2024

A model showed that if a vaccine coverage of 66% were achieved—similar to flu vaccination coverage—it could have a budget impact of $6.48 billion over the first RSV season.

Vaccines 198

Vaccines 198

Drug Topics

DECEMBER 24, 2023

Vaccine approvals included two immunizations for RSV and a new pentavalent meningococcal shot.

Vaccines 196

Vaccines Immunization 196

Drug Topics

MARCH 19, 2024

The biotechnology company’s recombinant spike protein-based vaccine demonstrated an efficacy of 88% after 40 days, 82% after 120 days, and 77% after 180 days during the PREVENT-19 trial.

Vaccines 232

Vaccines 232

Drug Topics

JANUARY 10, 2024

The estimated efficacy of the vaccine against documented infection for children and adolescents during the Omicron wave was 74.3% and 85.5%, respectively.

Vaccines 219

Vaccines Documentation 219

STAT

APRIL 10, 2024

SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade. The promise has long been an affordable, personalized cancer vaccine that could train the immune system to recognize proteins from cancer cells and, subsequently, destroy the tumor.

Vaccines 145

Vaccines Immunization 145

Drug Topics

DECEMBER 14, 2023

While either vaccine offers some protection, having both vaccines offers the strongest level of protection against hospitalization and severe complications like MIS-C, and death.

Vaccines 181

Vaccines Hospitals 181

Drug Topics

OCTOBER 30, 2023

Prophylactic HPV vaccines have demonstrated remarkable efficacy, exceeding 98%, and they are already proving to be effective in the prevention of anogenital warts, precancerous lesions, and cancer alike.

Vaccines 201

Vaccines 201

STAT

MARCH 25, 2024

A key factor in taming the pandemic was the creation of effective vaccines , which have saved millions of lives. You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. Merck, which saw its vaccine efforts fail twice, is up 56%.

Vaccines 145

Vaccines 145

Fierce Pharma

APRIL 18, 2024

vaccine commercial group. vaccine commercial group. During a busy period of overhaul at Sanofi, the company is restructuring its U.S. During a busy period of overhaul at Sanofi, the company is restructuring its U.S.

Vaccines 124

Vaccines 124

Drug Topics

JANUARY 15, 2024

Data has indicated a potential association between COVID-19 vaccination and menstruation, but there is little evidence about this association based on chart-reviewed medical record data.

Vaccines 186

Vaccines Medical Records 186

Drug Topics

FEBRUARY 13, 2024

Drug Topics talked with Gregg Sylvester, MD, chief health officer and vice president of medical affairs at CSL Seqirus, about what can we learn from this unique situation to improve future vaccine development and distribution.

Vaccines 201

Vaccines 201

Drug Topics

JANUARY 17, 2024

A panel of clinicians gathered to address concerns and report preliminary findings around rates of RSV incidence, hospitalization, and vaccination.

Vaccines 187

Vaccines Hospitals 187

STAT

FEBRUARY 1, 2024

A study published in the CDC’s online journal Morbidity and Mortality Weekly Report showed that the updated vaccine was essentially equally effective at protecting against the strain targeted by the vaccine — called XBB.1.5 1 subvariant, which emerged after the vaccine was made. 1.5 — and the JN.1

Vaccines 145

Vaccines 145

Drug Topics

JANUARY 3, 2024

The vaccine, called mRNA-1345, demonstrated an efficacy of 83.7% against RSV-associated lower respiratory tract disease with at least 2 signs or symptoms and 82.4% against the disease with at least 3 signs or symptoms.

Vaccines 209

Vaccines 209

Drug Topics

JANUARY 30, 2024

Findings from a recent study showed that participants who watched a video discussing COVID-19 vaccination had significantly higher knowledge scores compared to those who did not watch it.

Vaccines 199

Vaccines 199

Drug Topics

APRIL 4, 2024

Understanding the role of pharmacies in vaccination rates can help prepare officials for the next public health emergency.

Vaccines 154

Vaccines 154

STAT

MARCH 5, 2024

When Americans line up for flu vaccines next fall, they will almost certainly be getting vaccines that no longer contain protection against a family of flu viruses that appears to be extinct.

Vaccines 127

Vaccines FDA 127

STAT

FEBRUARY 27, 2024

An unprecedented shortage of cholera vaccine has public health experts fearing that a recent surge of outbreaks across developing countries will only worsen, a situation they argue is as regrettable as it was avoidable. Those numbers will almost certainly rise amid the worst vaccine shortage since an oral vaccine was introduced in the 1990s.

Vaccines 144

Vaccines 144

STAT

SEPTEMBER 11, 2023

The Food and Drug Administration announced Monday that it had greenlit two   updated Covid-19 booster shots in people as young as 6 months old, triggering a process that could see the Moderna and Pfizer-BioNTech vaccines become available in doctors’ offices, clinics, and pharmacies later this week. Read the rest…

Vaccines 145

Vaccines FDA 145

Pharmacy Times

MARCH 27, 2024

The adjuvanted RSVPreF3 vaccine could prevent nearly 3 million symptomatic RSV-ARI cases among US older adults over 3 years’ time, according to study results.

Vaccines 149

Vaccines 149

Drug Topics

FEBRUARY 14, 2023

The updated vaccine schedule includes vaccinations for influenza, pneumococcal disease, measles, mumps, and rubella (MMR) and COVID-19.

Vaccines 187

Vaccines 187

Drug Topics

JANUARY 16, 2024

Within a 12-month time frame, adjusted vaccine effectiveness against diagnosed long and probable long COVID was 41.7% and 35.4%, respectively.

Vaccines 193

Vaccines 193

STAT

JANUARY 21, 2024

LONDON — Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon — a day that global health officials say marked a historic step in the decades-long quest to protect people from one of the world’s deadliest infections.

Vaccines 145

Vaccines Immunization 145

pharmaphorum

JANUARY 10, 2024

Novavax is a leading pharmaceutical company dedicated to creating protein-based vaccines for diseases like COVID-19 and malaria. Learn more about their innovative vaccine development process and their commitment to creating a healthier future.

Vaccines 124

Vaccines Pharmaceutical Companies Pharmaceutical Companies 124

European Pharmaceutical Review

MARCH 26, 2024

Moderna’s next-generation COVID-19 vaccine mRNA-1283 demonstrated a higher immune response against SARS-CoV-2, interim results from the company’s Phase III trial show. These findings were based on data comparing the treatment to mRNA-1273.222 (Spikevax ® ), Moderna’s licensed vaccine for the condition. Moderna’s Spikevax XBB.1.5-adapted

Vaccines 97

Vaccines Immunization 97

STAT

FEBRUARY 12, 2024

A new study has shown that people vaccinated against Ebola who still developed the disease had a substantially lower risk of dying than people who were not vaccinated, even if they received the vaccine when they were already infected with the virus. Read the rest…

Vaccines 145

Vaccines 145

Pharmacy Times

DECEMBER 15, 2023

The proposed Vaccine Injury Compensation Modernization Act is intended to bring valuable updates to the 36-year-old legislation.

Vaccines 139

Vaccines 139

STAT

FEBRUARY 15, 2024

The Department of Health and Human Services announced Thursday that it is filling eight vacancies, including the chairmanship, on an important advisory panel on vaccine policy that was down to less than half of its normal roster for months.

Vaccines 140

Vaccines Immunization 140

STAT

FEBRUARY 28, 2024

has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily fallen over the past decade and took an even greater dip during the height of the Covid-19 pandemic. LONDON — Facing a growing outbreak of measles, the U.K.

Immunization 140

Immunization Vaccines 140

Drug Topics

OCTOBER 31, 2023

The combination vaccine produced robust immune responses from vaccine candidates in a phase 1/2 clinical trial.

Vaccines 200

Vaccines Immunization 200

Drug Topics

OCTOBER 20, 2022

Adults who receive influenza and pneumococcal vaccines may be more likely to receive COVID-19 vaccines and boosters.

Vaccines 195

Vaccines 195

Fierce Pharma

APRIL 1, 2024

While the market for COVID-19 vaccines has been shrinking lately, an investigation into text messages between Pfizer CEO Albert Bourla and the European Commission’s President Ursula von der Leyen r | The European Public Prosecutor’s Office (EPPO) took over the investigation into COVID vaccine negotiations between the European Commission's president (..)

Vaccines 126

Vaccines 126

Pharmacy Times

MARCH 6, 2024

This episode highlights how celebrity endorsements and local influencers can be leveraged to address vaccine hesitancy by shaping attitudes, but also must account for factors like audience trust and the potential for both benefits and limitations.

Vaccines 139

Vaccines 139